| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 21 | 2018 | 247 | 2.860 |
Why?
|
| Mammary Glands, Animal | 18 | 2018 | 481 | 2.340 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2018 | 723 | 1.160 |
Why?
|
| Breast Neoplasms | 16 | 2018 | 2498 | 1.110 |
Why?
|
| Precancerous Conditions | 6 | 2012 | 282 | 1.040 |
Why?
|
| Carcinogens | 8 | 2009 | 152 | 0.930 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2011 | 139 | 0.870 |
Why?
|
| Progesterone | 7 | 2005 | 623 | 0.690 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 291 | 0.680 |
Why?
|
| Neoplasm Transplantation | 6 | 2014 | 374 | 0.650 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2012 | 63 | 0.620 |
Why?
|
| Estrogens | 5 | 2005 | 513 | 0.620 |
Why?
|
| Mammary Glands, Human | 4 | 2012 | 79 | 0.590 |
Why?
|
| Stromal Cells | 3 | 2014 | 299 | 0.510 |
Why?
|
| Mice, Inbred BALB C | 14 | 2018 | 1004 | 0.510 |
Why?
|
| Mice | 37 | 2016 | 17639 | 0.510 |
Why?
|
| Tamoxifen | 4 | 2018 | 363 | 0.460 |
Why?
|
| Estrogen Receptor alpha | 5 | 2013 | 468 | 0.450 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 28 | 0.440 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 7 | 2009 | 57 | 0.440 |
Why?
|
| Morphogenesis | 2 | 2012 | 211 | 0.430 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 29 | 0.410 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 33 | 0.400 |
Why?
|
| Animals | 42 | 2018 | 34081 | 0.400 |
Why?
|
| Epithelial Cells | 10 | 2013 | 909 | 0.400 |
Why?
|
| Antigens, CD | 1 | 2014 | 420 | 0.390 |
Why?
|
| Laminin | 1 | 2012 | 69 | 0.390 |
Why?
|
| Proteoglycans | 1 | 2012 | 88 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 1895 | 0.380 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 53 | 0.380 |
Why?
|
| Glycoproteins | 1 | 2014 | 368 | 0.380 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 118 | 0.380 |
Why?
|
| Aneuploidy | 4 | 2013 | 152 | 0.360 |
Why?
|
| Collagen | 1 | 2012 | 315 | 0.350 |
Why?
|
| Peptides | 1 | 2014 | 796 | 0.350 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2013 | 106 | 0.350 |
Why?
|
| Models, Biological | 2 | 2012 | 1459 | 0.320 |
Why?
|
| Chromosomal Instability | 3 | 2008 | 57 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 56 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 616 | 0.300 |
Why?
|
| Estradiol | 3 | 2014 | 535 | 0.300 |
Why?
|
| Quinazolines | 1 | 2009 | 174 | 0.290 |
Why?
|
| Breast | 3 | 2007 | 214 | 0.290 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 4352 | 0.270 |
Why?
|
| Sulfonamides | 1 | 2009 | 261 | 0.270 |
Why?
|
| Receptors, Estrogen | 5 | 2018 | 797 | 0.270 |
Why?
|
| Genes, p53 | 3 | 2007 | 212 | 0.270 |
Why?
|
| Cell Growth Processes | 5 | 2013 | 63 | 0.260 |
Why?
|
| Pyrazoles | 1 | 2009 | 306 | 0.260 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 285 | 0.260 |
Why?
|
| Mice, SCID | 4 | 2016 | 568 | 0.240 |
Why?
|
| Hyperplasia | 5 | 2008 | 208 | 0.240 |
Why?
|
| Female | 39 | 2018 | 66491 | 0.230 |
Why?
|
| Cell Cycle Proteins | 7 | 2008 | 642 | 0.220 |
Why?
|
| Cell Cycle | 3 | 2014 | 610 | 0.220 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2003 | 100 | 0.200 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 16 | 0.190 |
Why?
|
| Progestins | 1 | 2002 | 48 | 0.190 |
Why?
|
| Separase | 3 | 2013 | 29 | 0.180 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 256 | 0.180 |
Why?
|
| Rats | 8 | 2010 | 3677 | 0.180 |
Why?
|
| Cell Division | 5 | 2004 | 777 | 0.170 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 2393 | 0.170 |
Why?
|
| Graft Survival | 2 | 2012 | 536 | 0.170 |
Why?
|
| Cyclins | 3 | 2004 | 101 | 0.160 |
Why?
|
| Immunoenzyme Techniques | 5 | 2012 | 258 | 0.150 |
Why?
|
| Epithelium | 2 | 2012 | 362 | 0.140 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3732 | 0.130 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2016 | 27 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 43 | 0.130 |
Why?
|
| Endopeptidases | 2 | 2008 | 114 | 0.130 |
Why?
|
| Humans | 23 | 2018 | 124602 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2010 | 341 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2012 | 1888 | 0.120 |
Why?
|
| Disease Progression | 3 | 2013 | 2047 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 143 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2007 | 465 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 208 | 0.110 |
Why?
|
| AC133 Antigen | 1 | 2014 | 35 | 0.110 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 3339 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 132 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 90 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 806 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 79 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 103 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2014 | 226 | 0.110 |
Why?
|
| Culture Media | 1 | 2014 | 182 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 54 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2013 | 1102 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2014 | 330 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 45 | 0.100 |
Why?
|
| Cell Proliferation | 5 | 2016 | 2287 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 178 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 81 | 0.100 |
Why?
|
| Nicotinic Acids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Apoptosis | 4 | 2014 | 1789 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 227 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 82 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 55 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 357 | 0.100 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2012 | 47 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1690 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2014 | 717 | 0.100 |
Why?
|
| Transcriptome | 1 | 2018 | 952 | 0.090 |
Why?
|
| Pregnancy | 7 | 2010 | 7182 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 267 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2012 | 176 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 27 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3040 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 617 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 665 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 293 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 307 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 2044 | 0.080 |
Why?
|
| Parity | 1 | 2010 | 78 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 183 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 778 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2010 | 150 | 0.080 |
Why?
|
| Celecoxib | 1 | 2009 | 32 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 1022 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 71 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 64 | 0.080 |
Why?
|
| Stem Cells | 1 | 2013 | 692 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 538 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 31 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 55 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 281 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1544 | 0.070 |
Why?
|
| Incidence | 3 | 2013 | 3138 | 0.070 |
Why?
|
| Lactation | 2 | 2005 | 193 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1660 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 6292 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 159 | 0.070 |
Why?
|
| Centrosome | 2 | 2007 | 35 | 0.070 |
Why?
|
| Phenotype | 3 | 2013 | 4256 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2004 | 60 | 0.070 |
Why?
|
| Heterozygote | 1 | 2009 | 672 | 0.070 |
Why?
|
| Risk | 1 | 2008 | 755 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 707 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 573 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 169 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 7 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 286 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2634 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2013 | 797 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 882 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 129 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1500 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 419 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 325 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 3090 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3153 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 1615 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 183 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2002 | 45 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 878 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 71 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2816 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2002 | 135 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 457 | 0.050 |
Why?
|
| CD24 Antigen | 2 | 2013 | 29 | 0.050 |
Why?
|
| Integrin beta1 | 2 | 2013 | 53 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 616 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2002 | 332 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 969 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 460 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1182 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1485 | 0.040 |
Why?
|
| Rats, Inbred WF | 3 | 2007 | 21 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2004 | 816 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 759 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1284 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1597 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 205 | 0.030 |
Why?
|
| Pregnancy, Animal | 2 | 2010 | 76 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 4409 | 0.030 |
Why?
|
| Genotype | 1 | 2002 | 2556 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2583 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 99 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 18 | 0.030 |
Why?
|
| Aurora Kinases | 2 | 2007 | 31 | 0.030 |
Why?
|
| Aurora Kinase A | 2 | 2007 | 39 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1016 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 4503 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 383 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2005 | 112 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 114 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 222 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2014 | 125 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 137 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 413 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 457 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 57 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 3063 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 289 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 161 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 240 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 763 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 572 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 699 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 11 | 0.020 |
Why?
|
| Claudins | 1 | 2011 | 29 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 230 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 869 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 338 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 10270 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1702 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 80 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 186 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 662 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 504 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 398 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 311 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 359 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 20 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 45 | 0.020 |
Why?
|
| Chromatids | 1 | 2008 | 43 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 68 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 45 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 44 | 0.020 |
Why?
|
| Tetracycline | 1 | 2008 | 77 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 211 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 822 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 395 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 52 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 96 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2007 | 76 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Polyploidy | 1 | 2007 | 15 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1231 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 328 | 0.020 |
Why?
|
| United States | 1 | 2002 | 10887 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 548 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 453 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 949 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2750 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 125 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 113 | 0.020 |
Why?
|
| Menopause | 1 | 2005 | 75 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2005 | 82 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 386 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 60 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 837 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1273 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 4795 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 100 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 348 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2002 | 14 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 486 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 61 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 46 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 95 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6533 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 145 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 103 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 546 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 461 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 862 | 0.010 |
Why?
|
| Male | 3 | 2016 | 61198 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9014 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1562 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 606 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1586 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2705 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 996 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3878 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 748 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19703 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 26714 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 29440 | 0.010 |
Why?
|